| (SEK) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 4.29M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CLBIO.ST returned +50.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +11.9% |
| 1 year | +50.4% |
| 5 years | +24.0% |
| 10 years | +119.0% |
| All-time high | kr 26.74 (Sep 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in CLBIO.ST would be worth today ›No. Corline Biomedical AB has not paid a dividend in the past 12 months.
Corline Biomedical AB is part of the Healthcare sector.
Corline Biomedical AB has a market cap of 492.61M SEK, based on the latest quote.
